# Arrow Financial Corp: overview

AROW · Nasdaq · CIK 717538 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/arow.md) · [Financials](/companies/arow/financials.md) · [Filings](/companies/arow/filings.md) · [Insiders](/companies/arow/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [0.53](/filings/0000717538-25-000102.md) | not reported | [0.38](/filings/0000717538-26-000060.md) | [0.65](/filings/0000717538-26-000117.md) | [0.77](/filings/0000717538-25-000102.md) | not reported | [0.82](/filings/0000717538-26-000060.md) | [0.66](/filings/0000717538-26-000117.md) |
| Free cash flow | $m | [8.1 d](/filings/0000717538-25-000102.md) | [4.1 d](/filings/0000717538-26-000037.md) | [8.8](/filings/0000717538-26-000060.md) | [8.3 d](/filings/0000717538-26-000117.md) | [14.3 d](/filings/0000717538-25-000102.md) | [4.8 d](/filings/0000717538-26-000037.md) | [13.9](/filings/0000717538-26-000060.md) | [11.6 d](/filings/0000717538-26-000117.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [2.92](/filings/0000717538-24-000047.md) | [2.86](/filings/0000717538-25-000023.md) | [1.77](/filings/0000717538-26-000037.md) | [1.77](/filings/0000717538-26-000037.md) | [2.65](/filings/0000717538-26-000037.md) |
| Free cash flow | $m | [61.1](/filings/0000717538-24-000047.md) | [45.5](/filings/0000717538-25-000023.md) | [13.5](/filings/0000717538-26-000037.md) | [28.9](/filings/0000717538-26-000037.md) | [36.2](/filings/0000717538-26-000037.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/arow/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Arrow Financial Corp](/funds/717538.md) | 2026-06-30 | $76.2m | 1,859,963 |  | Reduced −18,876 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $57.4m | 1,399,785 |  | Added +148,528 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $29.7m | 725,492 |  | Reduced −4,979 |
| [Rhino Investment Partners, Inc](/funds/1828776.md) | 2026-06-30 | $26.1m | 847,563 |  | New +847,563 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $25.6m | 623,719 |  | Reduced −13,808 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $20.1m | 490,098 |  | Added +151,943 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $17.7m | 432,990 |  | Added +89,734 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $16.8m | 409,589 |  | Added +38,798 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $9.2m | 224,482 |  | Added +46,673 |
| [HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC](/funds/1164833.md) | 2026-06-30 | $7.8m | 189,939 |  | Added +3,700 |

## Recent filings

[All 1,644 filings](/companies/arow/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-14 | 16:46 ET | [8-K/A](/filings/0000717538-26-000127.md) | 9.01 Financial statements and exhibits | 0000717538-26-000127 |
| 2026-09-10 | 08:45 ET | [8-K](/filings/0000717538-26-000123.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000717538-26-000123 |
| 2026-08-06 | 13:50 ET | [10-Q](/filings/0000717538-26-000117.md) | Quarterly report, period 2026-06-30 | 0000717538-26-000117 |
| 2026-07-23 | 07:29 ET | [8-K](/filings/0000717538-26-000110.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000717538-26-000110 |
| 2026-07-01 | 07:42 ET | [8-K](/filings/0000717538-26-000100.md) | 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000717538-26-000100 |
| 2026-06-11 | 07:59 ET | [8-K](/filings/0000717538-26-000090.md) | 8.01 Other events | 0000717538-26-000090 |
| 2026-06-04 | 09:01 ET | [8-K](/filings/0000717538-26-000085.md) | 5.07 Shareholder vote results | 0000717538-26-000085 |
| 2026-06-03 | 09:59 ET | [8-K](/filings/0000717538-26-000081.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000717538-26-000081 |
| 2026-06-01 | 16:30 ET | [8-K](/filings/0000717538-26-000070.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000717538-26-000070 |
| 2026-05-08 | 10:38 ET | [10-Q](/filings/0000717538-26-000060.md) | Quarterly report, period 2026-03-31 | 0000717538-26-000060 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000717538-26-000037.md), filed Mar 6, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 717538
- Tickers: AROW
- Exchange: Nasdaq
- SIC code: 6021 National Commercial Banks
- State of incorporation: NY
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 08:06 ET. No prices; not investment advice.